Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia
The biguanide metformin has been used as first-line therapy in type 2 diabetes mellitus (T2DM) treatment for several decades. In addition to its glucose-lowering properties and its prevention of weight gain, the landmark UK Prospective Diabetes Study (UKPDS) demonstrated cardioprotective properties...
Saved in:
Main Authors: | Wiebe M. C. Top (Author), Adriaan Kooy (Author), Coen D. A. Stehouwer (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of early life adversity with cardiovascular disease and its potential mechanisms: a narrative review
by: Huiying Tan, et al.
Published: (2024) -
Metformin: a review of its potential indications
by: Wang YW, et al.
Published: (2017) -
Potential anti-cancer features of metformin
by: Aleksandra Puła, et al.
Published: (2022) -
Cardiovascular Effects of Metformin
by: B. T. Kurmanbekova, et al.
Published: (2022) -
Metformin and the risk of dementia based on an analysis of 396,332 participants
by: Shiliang Ji, et al.
Published: (2022)